Overview

Pilot Study for First Clinical Use of sc2Wear Furosemide Combination Product

Status:
Completed
Trial end date:
0000-00-00
Target enrollment:
Participant gender:
Summary
The proposed pilot study aims to gain experience with the first clinical use of the to-be marketed drug-device combination product, the sc2Wear Furosemide Combination Product and to assess methods and procedures for evaluation of product performance. The objectives of this study are: - To gain first in man experience of a novel drug-device combination product - To evaluate the suitability of the methods and procedures for evaluating of the performance of the sc2Wear Pump
Phase:
Phase 2
Details
Lead Sponsor:
scPharmaceuticals, Inc.
Treatments:
Furosemide